Ensereptide

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameEnsereptide
Drug Alias NamePXL-01
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionInterleukin-6 inhibitorsInterleukin-1 beta inhibitorsInterleukin-8 inhibitors
TargetsInterleukin-6Interleukin-1 betaInterleukin-8
Therapy Area/IndicationsPost-surgical adhesionsTissue AdhesionsCicatrix
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwedenDenmarkGermany
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesPromore Pharma
China Registration ClassN/A

Develop Information

Active CompaniesPromore PharmaPharmaresearch ProductsTechnomark Life Sciences
Inactive CompaniesPergamum Ab
Active IndicationsPost-surgical adhesionsCicatrix
Inactive IndicationsTissue Adhesions

Other Information

ATC CodeN/A
Related LinksN/A